Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
about
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisAre nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?Two outward potassium current types are expressed during the neural differentiation of neural stem cellsDifferentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapiesLithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord.The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies.Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.Cell-based therapy approaches: the hope for incurable diseases.Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases.Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelination.Resveratrol Induces Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Neuron-Like Cells.Co-Transplantation of Human Neurotrophic Factor Secreting Cells and Adipose-Derived Stem Cells in Rat Model of Multiple Sclerosis.Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro.Cell-based therapeutic strategies for multiple sclerosis.Improved Proliferative Capacity of NP-Like Cells Derived from Human Mesenchymal Stromal Cells and Neuronal Transdifferentiation by Small Molecules.Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats.Stem cell therapy in multiple sclerosis: a future perspective.Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.Valproic acid enhances the neural differentiation of human placenta derived-mesenchymal stem cells in vitro.Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.Therapeutic Efficacy of Mesenchymal Stem Cells and Mesenchymal Stem Cells-derived Neural Progenitors in Experimental Autoimmune Encephalomyelitis.Mesenchymal Stem Cell-derived Neural Progenitor Cells in Progressive Multiple Sclerosis: Great Expectations.
P2860
Q26744629-8047AF34-A6D5-4FFD-B578-EC3BE36A8F10Q33757255-8751A747-470B-4EAB-B362-476B2A1A6C2FQ34095139-A704629A-7EB4-4EE5-97C8-1921BC065268Q34428273-70A3973D-A501-424B-B6B5-F30EAF3CEBB0Q34468304-594A2C86-C9C2-484A-8713-1A8B396EA451Q34512363-0443C0E2-E8B0-4338-A917-40FE67EA43C5Q35632053-77DAE83F-3E5D-48BB-95AB-008023E3F508Q37003127-B830CD11-581A-46DD-90E8-2C83DC706A1EQ38186029-36519EA3-B7C0-4254-8999-A45D1F185CE0Q38257152-F6BD9B4C-9AC5-4F10-81C8-421E43A68AF5Q38265206-46E39B1D-41EA-48A4-98ED-32DD64221CA4Q39279957-26C03530-91F6-448E-A925-DBDCA8AAB53BQ39356461-A7C89902-242B-4215-A8E5-501F664D28F5Q40966857-FCBCDB4F-8158-473E-BBAC-B630C3393950Q42289761-753C0DBA-53BF-4729-ABA2-EFA72DBB3452Q47225588-229102FB-6DDF-4DF5-B89E-48DF184E7E49Q47363542-33A891C6-12A4-488A-8344-6FE300F72B2DQ47885870-136B0AD2-DCA2-4708-BE56-FE00F5D59E45Q48253551-27F65EEB-99E5-402E-B216-482A507F004AQ48346065-AA8DCCDD-2557-4506-B658-D4BE88776085Q48450832-52E05D6B-8A69-4A9D-A536-F8B4EC80487EQ49343380-DB353423-A398-4CB6-8B7C-C8D04E898933Q49961729-3AB8B5DA-D5AC-4990-AA75-B0F72747E9A8Q51363081-F4687D8D-8B5C-4866-9DC1-6EB82FA95380Q52624498-44A1C245-F73A-4EF6-B7EB-EA13DF5363A9Q55090787-8C780155-39FB-4D9B-8331-F46D4973A4ABQ55400340-A88D36C0-DB72-42F1-B9AE-93EA5424A7D7
P2860
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Characterization of autologous ...... cations in multiple sclerosis.
@en
type
label
Characterization of autologous ...... cations in multiple sclerosis.
@en
prefLabel
Characterization of autologous ...... cations in multiple sclerosis.
@en
P2093
P2860
P356
P1476
Characterization of autologous ...... cations in multiple sclerosis.
@en
P2093
Raihan Faroqui
Saud A Sadiq
Tamara Vyshkina
Violaine K Harris
P2860
P304
P356
10.5966/SCTM.2012-0015
P577
2012-06-28T00:00:00Z